Accessibility Menu
ProPhase Labs logo

ProPhase Labs

(OTC) PRPH

Current Price$0.08
Market Cap$717.70K
Since IPO (1992)-97%
5 YearN/A
1 YearN/A
1 Month-27%

ProPhase Labs Financials at a Glance

Market Cap

$717.70K

Revenue (TTM)

$4.35M

Net Income (TTM)

-$14.74M

EPS (TTM)

-$4.90

P/E Ratio

-0.02

Dividend

$0.00

Beta (Volatility)

1.95 (High)

Price

$0.08

Volume

4,041

Open

$0.08

Previous Close

$0.08

Daily Range

$0.08 - $0.08

52-Week Range

$0.07 - $0.34

Estimated Earnings Date

Jun 22, 2026

PRPH News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ProPhase Labs

Industry

Pharmaceuticals

Employees

19

CEO

Ted William Karkus, MBA

Headquarters

Garden City, NY 11530, US

PRPH Financials

Key Financial Metrics (TTM)

Gross Margin

32%

Operating Margin

-4%

Net Income Margin

-3%

Return on Equity

0%

Return on Capital

-3%

Return on Assets

-25%

Earnings Yield

-50.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$717.70K

Shares Outstanding

9.49M

Volume

4.04K

Avg. Volume

89.57K

Financials (TTM)

Gross Profit

$1.38M

Operating Income

-$18.05M

EBITDA

-$11.40M

Operating Cash Flow

-$8.94M

Capital Expenditure

$0.00

Free Cash Flow

-$8.94M

Cash & ST Invst.

$90.00K

Total Debt

$8.62M

ProPhase Labs Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$784.00K

+131.6%

Gross Profit

$247.00K

-73.3%

Gross Margin

31.51%

N/A

Market Cap

$717.70K

N/A

Market Cap/Employee

$7.48K

N/A

Employees

96

N/A

Net Income

-$7.40M

+78.5%

EBITDA

$1.29M

+109.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$90.00K

-86.7%

Total Debt

$8.62M

-64.9%

Accounts Receivable

$1.54M

-92.3%

Inventory

$70.00K

-93.9%

Long Term Debt

$639.00K

-96.5%

Short Term Debt

$7.98M

+21.5%

Return on Assets

-24.62%

N/A

Return on Invested Capital

-2.66%

N/A

Free Cash Flow

$17.40M

+625.5%

Operating Cash Flow

$17.40M

+704.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SBFMSunshine Biopharma, Inc.
$2.05-3.76%
AEMDAethlon Medical, Inc.
$1.38-26.98%
ERNAErnexa Therapeutics Inc.
$5.89-5.00%
CODXCo-Diagnostics, Inc.
$3.12-7.42%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$16.08+0.01%
SPCXSpace Exploration Technologies
$154.60-0.16%
KEELKeel Infrastructure
$6.66+0.06%
SOFISoFi Technologies
$17.10-0.05%

Questions About PRPH

What is the current price of ProPhase Labs?

ProPhase Labs is trading at $0.08 per share.

What is the 52-week range for ProPhase Labs?

Over the past 52 weeks, ProPhase Labs has traded between $0.07 and $0.34.

How much debt does ProPhase Labs have?

As of the most recent reporting period, ProPhase Labs reported total debt of $8.62M.

How much cash does ProPhase Labs have on hand?

ProPhase Labs reported $90.00K in cash and cash equivalents in its most recent financial results.

What is ProPhase Labs’s dividend yield?

ProPhase Labs does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.